MICHAEL J PIERPOLINE

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease KANSAS CITY, KS NPI 1124414065

General Payments — all program years on this page

$3,233.80

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 57
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $295.47 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $295.4712

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Medtronic, Inc. $123.072
Amgen Inc. $45.853
BOSTON SCIENTIFIC CORPORATION $45.112
Acerta Pharma LLC $30.912
PFIZER INC. $19.261
Novo Nordisk AS $16.931
Lexicon Pharmaceuticals, Inc. $14.341

By program year

Program yearAmountRecords
2018 $436.668
2019 $1,174.4815
2021 $136.572
2022 $402.265
2023 $788.3615
2024 $295.4712

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1081734519 Lexicon Pharmaceuticals, Inc. $14.34 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092577665 Boston Scientific Corporation $22.12 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092577667 Boston Scientific Corporation $22.99 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096887538 Novo Nordisk Inc $16.93 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104369845 AstraZeneca Pharmaceuticals LP $17.60 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105270832 AstraZeneca Pharmaceuticals LP $13.31 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116019272 Amgen Inc. $14.55 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116019280 Amgen Inc. $14.73 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116019286 Amgen Inc. $16.57 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117168679 Medtronic, Inc. $23.81 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117168683 Medtronic, Inc. $99.26 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130988598 PFIZER INC. $19.26 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.